Bottom line
What is TSPRX's expense ratio?
TSPRX's expense ratio is 1.54%, or about $154 a year on every $10,000 invested. That is more expensive than 87% of small-cap funds we track (median 0.99%). It has no front-end sales load. Its expense ratio includes a 0.5% 12b-1 marketing fee.
Updated Feb 27, 2026
TSPRX fee table
| Net expense ratio | 1.54% |
|---|---|
| Gross expense ratio | 1.59% |
| Management fee | 0.87% |
| 12b-1 (distribution) fee | 0.5% |
| Other expenses | 0.22% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What TSPRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| TSPRX | $157 | $497 | $861 | $1,885 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.54% expense ratio costs roughly $81,400 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).